Structures by: Dallasta V.
Total: 8
C20H14N2O
C20H14N2O
Molecular pharmaceutics (2014) 11, 4 1151
a=21.452(5)Å b=21.452(5)Å c=13.200(3)Å
α=90.00° β=90.00° γ=90.00°
C18H17NO2
C18H17NO2
Molecular pharmaceutics (2014) 11, 4 1151
a=7.432(2)Å b=10.432(2)Å c=10.526(2)Å
α=74.242(3)° β=77.299(3)° γ=72.252(3)°
C17H15NO2
C17H15NO2
Molecular pharmaceutics (2014) 11, 4 1151
a=9.952(1)Å b=13.391(2)Å c=10.197(1)Å
α=90.000(5)° β=99.739(2)° γ=90.000(5)°
C36H28CuN2O4
C36H28CuN2O4
Molecular pharmaceutics (2014) 11, 4 1151
a=24.782(7)Å b=7.293(2)Å c=15.647(4)Å
α=90.00° β=92.667(4)° γ=90.00°
C34H24CuN2O4
C34H24CuN2O4
Molecular pharmaceutics (2014) 11, 4 1151
a=10.167(1)Å b=21.499(1)Å c=12.025(1)Å
α=90.00° β=93.542(2)° γ=90.00°
C20H18Cl4Cu2N10S2,1.5(H2O)
C20H18Cl4Cu2N10S2,1.5(H2O)
Journal of medicinal chemistry (2007) 50, 8 1916-1924
a=8.827(2)Å b=10.796(5)Å c=16.590(8)Å
α=72.92(2)° β=85.50(2)° γ=66.58(2)°
C9H11Cl2CuN5S
C9H11Cl2CuN5S
Journal of medicinal chemistry (2007) 50, 8 1916-1924
a=8.649(3)Å b=9.313(5)Å c=9.371(4)Å
α=68.69(2)° β=71.86(2)° γ=79.27(2)°
C14H14CL4Cu2N10
C14H14CL4Cu2N10
Journal of medicinal chemistry (2007) 50, 8 1916-1924
a=8.3460(10)Å b=14.280(4)Å c=8.376(3)Å
α=90.00° β=93.43(2)° γ=90.00°